Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development

2018 ◽  
Vol 208 (1) ◽  
pp. 3-24 ◽  
Author(s):  
Volker Lohmann
Hepatology ◽  
2010 ◽  
Vol 53 (1) ◽  
pp. 32-41 ◽  
Author(s):  
Emmanuel Thomas ◽  
Jordan J. Feld ◽  
Qisheng Li ◽  
Zongyi Hu ◽  
Michael W. Fried ◽  
...  

Lab Animal ◽  
2005 ◽  
Vol 34 (2) ◽  
pp. 39-47 ◽  
Author(s):  
Chandan Guha ◽  
Sung-W Lee ◽  
Namita Roy Chowdhury ◽  
Jayanta Roy Chowdhury

Viruses ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 211
Author(s):  
Chui-Wa So ◽  
Glenn Randall

Hepatocytes, the major target of hepatitis C virus (HCV), are highly polarized. HCV infection requires extensive trafficking to distinct subcellular domains in the polarized hepatocyte. Polarized cells and three-dimensional organoids are commonly used to study liver functions and differentiation. Researchers have begun adapting these cell culture models that morphologically and physiologically resemble hepatocytes in vivo to study HCV infection. This review summarizes the use of three-dimensional cell culture systems in studies of HCV infection.


2006 ◽  
Vol 44 (01) ◽  
Author(s):  
T von Hahn ◽  
M Flint ◽  
BD Lindenbach ◽  
A Boullier ◽  
O Quehenberger ◽  
...  

JMS SKIMS ◽  
2020 ◽  
Vol 23 (1) ◽  
pp. 3-15
Author(s):  
Saleem Kamili ◽  
Hisham Qadri

Hepatitis C, caused by hepatitis C virus (HCV) was originally described as parenterally transmitted non-A non-B hepatitis. Since its discovery in 1989, the field of HCV research has become a shining example of successful translation of basic research wherein in a short of span of just 30 years the virus was discovered, highly sensitive and specific diagnostic assays were developed, epidemiology and clinical characteristics of the disease were well defined and now with the availability of highly efficacious antiviral therapies many countries are already on their way to achieving World Health Organization’s (WHO) elimination targets of hepatitis C by 2030.  However, much work needs to be done to eliminate hepatitis C especially in resource poor countries. Most recent data show an estimated 71 million people are currently infected with HCV worldwide and approximately 400,000 people die each year from causes related to HCV. Of these estimates, more than 13 million HCV infected persons are in India and Pakistan (Figure 1). Despite the availability of a cure for hepatitis C, only 20% of those infected patients have been diagnosed (1). In order to achieve the WHO targets of hepatitis C elimination, concerted efforts will have to made to make affordable and reliable diagnostics available worldwide.


Sign in / Sign up

Export Citation Format

Share Document